Early Breast Cancer: LHRH Agonists Show Considerable Promise
Friday, October 10, 2008 - 11:28
in Health & Medicine
Women who have had early stage breast cancer surgically removed, and whose tumor cells are stimulated by the hormone estrogen, can benefit from taking luteinizing hormone releasing hormone antagonists, a Cochrane systematic review has concluded. This medication may be taken alone or alongside the use of tamoxifen.
Read the whole article on Science Daily
More from Science Daily
Related
- Early breast cancer: LHRH agonists show considerable promiseTue, 7 Oct 2008, 19:35:58 EDT
- Previously unseen switch regulates breast cancer response to estrogenThu, 8 May 2008, 15:07:32 EDT
- Goserelin improves long-term survival in premenopausal women with early breast cancerTue, 24 Feb 2009, 18:16:24 EST
- New evidence of hormone therapy causing breast cancer, Stanford professor saysWed, 4 Feb 2009, 17:44:21 EST
- Test for hormones in blood not reflective of hormones in breast tissue; breast cancer riskWed, 22 Apr 2009, 10:44:53 EDT